HARVARD
He has this unusual ability to sit at the intersection of immunology, AI, and medicine and actually create something useful out of it. A lot of people work in those areas, but very few connect them in a way that produces tools applicable to real human health.
Vadim Gladyshev
Professor of Medicine, Harvard Medical School
STANFORD
What I find most impressive is David's end-to-end approach—from uncovering biological signals using AI and ML, to developing them into longevity biomarkers, and finally into real-world systems that people can actually use.
Michael Snyder
Stanford W. Ascherman Professor of Genetics, Stanford University
NUS SINGAPORE
Longevity research is increasingly about interpreting complex human datasets and developing translational approaches to promote longer, healthier lives. David combines analysis and translation in a state-of-the-art manner and is at the forefront of the field.
Brian Kennedy
Distinguished Professor of Biochemistry & Physiology, National University of Singapore
HARVARD · MIT
He's done terrific work on aging biomarkers and human cohort-based aging clocks that are utilized in real-world settings.
George Church
Professor of Genetics, Harvard Medical School & MIT
EINSTEIN
Geroscience flourishes because aging drives age-related disease, and targeting this biology is the revolution that transforms our health. David Furman has shown that aging isn't passive or genetically fixed but continuously shaped by environment, behavior, and immune dynamics — reshaping how we approach prevention and longevity.
Nir Barzilai
Director, Institute for Aging Research, Albert Einstein College of Medicine
HLMS
David's work stands out because he treats the immune system as a high-dimensional sensor of human health, and then uses AI to decode those signals into biomarkers that predict functional decline and disease risk.
Evelyne Bischof
President, Healthy Longevity Medicine Society
UNIV. OF BASEL
He approaches intrinsic capacity and functional decline as a measurable output of underlying immune, epigenetic and molecular networks, which makes it far more actionable.
Heike A. Bischoff-Ferrari
Director, Swiss Campus for Healthy Longevity, University of Basel
WEILL CORNELL
Dr. Furman builds innovative methods to connect space biology to human health and longevity, using immune system responses in microgravity to uncover novel biological mechanisms and dynamics.
Chris Mason
WorldQuant Professor of Genomics, Weill Cornell Medicine
JACKSON LAB
David's work stands out for its ability to integrate multi-modal human data to identify immune aging biomarkers with real clinical utility — bridging the gap between computational discovery and actionable insights for healthy longevity.
Duygu Ucar
Professor, The Jackson Laboratory
XPRIZE
David's approach to predicting long-term human health outcomes is impressive and his inflammatory clocks are transformative because they quantify a core biological process that directly impacts clinical outcomes.
Jamie Justice
EVP, XPRIZE Foundation
AGING RESEARCH
David brings exceptional expertise in molecular and deep multi-omics profiling, combined with advanced AI, to uncover and understand the biological drivers of aging; he is a rigorous scientist with a clear and compelling vision.
Eric Verdin
President and CEO, Institute for Research on Aging
TOULOUSE UNIV.
To make discoveries for healthy aging we need competences in biology of aging, bioinformatics and AI, and the ability to understand the clinics. Very few are able to do it — David Furman is one of those few.
Bruno Vellas
Chair of the Gérontopôle, Toulouse University Hospital
ULTRAWELLNESS
He is among the few scientists who use AI not just for prediction, but to uncover the biological structure of aging and identify actionable targets within it.
Elizabeth Boham
Medical Director, The UltraWellness Center
LONGEVITY CENTER EUROPE
What makes David exceptional is that he has built an end-to-end framework, from biomarker data acquisition to AI-driven modeling to intervention discovery, that is both scientifically rigorous and practically deployable — with clear applicability in longevity clinics where it can be used to translate complex biological data into personalized, actionable interventions.
Joanna Bensz
Founder and CEO, Longevity Center Europe
UCLA
David's impressive contribution is not just new biomarkers, but a novel system using multi-omics and AI for discovering them, validating them, and translating them into interventions to extend healthspan and prevent disease.
Joy Kong
Triple Board-Certified Physician, UCLA
SUPERPOWER
David's research connects immune system dynamics, biomarker discovery, and intervention design into a single pipeline applicable to real-world problems, which is very rare in the field.
Max Marchione
Founder, Superpower